Privia Health Group Inc

PRVA has formed a clear Post-Capitulation mean-reversion pattern with tight absorption candles and reduced volume, suggesting forced selling is exhausted. With the stock deeply oversold and RSI turning up, timing now is favorable for a tactical buy into the support cluster. Medium-term mean-reversion permission anchors a bullish bias, while long-term uptrend remains intact. We target the absorption zone and shallow pullback into short-term EMAs for entry.

• ↑Q2 revenue reached $632.6M (+21.4% YoY), topping analyst estimates.
• ↑Net income surged 237% YoY to $9M, with adjusted EPS $0.19.
• ↓Complexity of state rollouts intensifies execution and integration risks.